2005, Number 1
<< Back Next >>
Rev Invest Clin 2005; 57 (1)
Antonio Ramos-De la Medina coments made to Uscanga’s manuscript
Ramos-De la Medina A
Language: Spanish
References: 7
Page: 98-99
PDF size: 33.24 Kb.
Text Extraction
No Abstract
REFERENCES
Zepeda-Gomez S, Nuncio JF, Maldonado H, Arista-Nasr J, Sánchez E, Schmulson M, Uscanga L. Gastrointestinal stromal tumors: clinical and pathological analysis of 24 cases. Rev Invest Clin 2004; 56: 443-8.
Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33: 459-65.
Berman J, O’Leary TJ. Gastrointestinal stromal tumor workshop. Hum Pathol 2001; 32: 578-82.
Greenson JK. Gastrointestinal stromal tumors and other mesenchymal lesions of the gut. Mod Pathol 2003; 16: 366-75.
Saund MS, Demetri GD, Ashley SW. Gastrointestinal stromal tumors (GISTs). Curr Opin Gastroenterol 2004; 20: 89-94.
Medina-Franco H, Ramos-De la Medina A, Cortes-Gonzalez R, Baquera J, Angeles-Angeles A, Urist MM, Eltoum IE, Heslin MJ. Expression of p53 and proliferation index as prognostic factors in gastrointestinal sarcomas. Ann Surg Oncol 2003; 10: 190-5.
Demetri GD, Desai J, Fletcher JA, Morgan JA, Fletcher CD, Kazanovicz A, Van Den Abbeele A, Baum C, Maki R, Heinrich MC. SU11248, a multi-targeted tyrosine kinase inhibitor, can overcome imatinib resistance caused by diverse genomic mechanisms in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2004. ASCO Annual Meeting Proceedings 2004; 14S: 3001.
Full text